Simulated Assessment of Pharmacokinetically Guided Dosing for Investigational Treatments of Pediatric Patients With Coronavirus Disease 2019Anil R. Maharaj, Michael Cohen‐Wolkowiez, Huali Wu et al.|Archives of Pediatrics and Adolescent Medicine|2020Cited by 47
Physiologically‐Based Pharmacokinetic Modeling Characterizes the CYP3A‐Mediated Drug‐Drug Interaction Between Fluconazole and Sildenafil in InfantsSara Salerno, Daniel González, Andrea N. Edginton et al.|Clinical Pharmacology & Therapeutics|2020Cited by 40
Development and Evaluation of a Virtual Population of Children with Obesity for Physiologically Based Pharmacokinetic ModelingJacqueline G. Gerhart, Robert H. Lurie, Fernando Carreño et al.|Clinical Pharmacokinetics|2021Cited by 39
Physiologically Based Pharmacokinetic Modeling of Meropenem in Preterm and Term InfantsSamit Ganguly, Andrea N. Edginton, Jacqueline G. Gerhart et al.|Clinical Pharmacokinetics|2021Cited by 33
Population pharmacokinetics of sildenafil in extremely premature infantsDaniel González, Christoph P. Hornik, Matthew M. Laughon et al.|British Journal of Clinical Pharmacology|2019Cited by 21